Andean highlanders adapt to thin air through epigenetic gene tuning, revealing a flexible, long-term path to altitude survival.
An aggressive breast cancer lacking common drug targets, triple-negative breast cancer may be countered by oridonin, a ...
Celcuity has successfully transitioned from a speculative biotechnology company to a pre-commercial firm with a de-risked ...
MINNEAPOLIS, Nov. 26, 2025 (GLOBE NEWSWIRE) -- Celcuity Inc. (Nasdaq: CELC), a clinical-stage biotechnology company pursuing development of targeted therapies for oncology, today announced its ...
Discover the essential role of TGF-Beta 1 in cellular regulation, its signaling pathway, and how TGF-β1 antibodies are used ...
Rakovina Therapeutics Inc. (“Rakovina” or the “Company”) (TSX-V: RKV)(FSE: 7JO0), a biopharmaceutical company advancing cancer therapies through AI-enabled drug discovery, today ...
India’s winter smog is silently disrupting metabolism, with doctors warning that toxic PM2.5 pollution is driving insulin ...
Can a desert plant improve diabetes? New research shows the fruit of Nitraria roborowskii Kom may reduce blood sugar and ...
Komal Jhaveri - Breast Medical Oncologist and Early Drug Development Specialist, Memorial Sloan Kettering Cancer Center, New York, ...
Under the microscope, liver and pancreas tissue from treated mice looked healthier and less damaged than tissue from untreated animals. For now, this desert berry is an interesting lead, not a proven ...